In a nonclinical trial setting , we sought to determine the proportion of individuals with coronary artery disease ( CAD ) with optimal risk factor levels based on the COURAGE ( Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation ) trial .